Neurotech International Limited Stock
Equities
NTI
AU000000NTI9
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.078 AUD | +4.00% | +1.30% | +13.04% |
Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
Sales 2022 | 608K 404K | Sales 2023 | 1.19M 795K | Capitalization | 34.96M 23.25M |
---|---|---|---|---|---|
Net income 2022 | -3M -2M | Net income 2023 | -7M -4.66M | EV / Sales 2022 | 77.3 x |
Net cash position 2022 | 1.9M 1.26M | Net cash position 2023 | 5.03M 3.34M | EV / Sales 2023 | 25.1 x |
P/E ratio 2022 |
-14.5
x | P/E ratio 2023 |
-4.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.23% |
1 day | +4.00% | ||
1 week | +1.30% | ||
Current month | -13.33% | ||
1 month | -15.22% | ||
3 months | -29.09% | ||
6 months | +36.84% | ||
Current year | +13.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | - | 22-03-07 | |
Erlyn Dawson
SEC | Corporate Secretary | - | 19-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Davies
CHM | Chairman | - | 19-04-15 |
Thomas Duthy
BRD | Director/Board Member | - | 22-08-31 |
Gerald Quigley
BRD | Director/Board Member | - | 22-07-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 0.078 | +4.00% | 1 016 294 |
24-05-20 | 0.075 | -3.85% | 676,463 |
24-05-17 | 0.078 | 0.00% | 2,194,593 |
24-05-16 | 0.078 | +4.00% | 369,204 |
24-05-15 | 0.075 | -2.60% | 897,430 |
Delayed Quote Australian S.E., May 20, 2024 at 08:50 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+13.04% | 53.05M | |
-13.48% | 2.95B | |
-16.39% | 84.22M |
- Stock Market
- Equities
- NTI Stock